Direct reprogramming for cardiac regeneration: from dream to reality.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Reprogramming approaches in cardiovascular regeneration.Current treatment options in cardiovascular medicine · 2014
   Article
2. Regenerative medicine: transforming the drug discovery and development paradigm.Cold Spring Harbor perspectives in medicine · 2014
   Review
3. Stem cells: potential and challenges for kidney repair.American journal of physiology. Renal physiology · 2014
   Review
4. Hippo signaling impedes adult heart regeneration.Development (Cambridge, England) · 2013
   Article

Corrections and comments

• Comment on
  MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes.2012

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as